“2020 will be remembered as the year of the biotech sector,” declares the author of today’s article, who proceeds to highlight two biotech stocks that Morgan Stanley is bullish on – and which have also earned “Strong Buy” consensus ratings from the analyst community at large. For these two biotech stocks with significant upside potential, CLICK HERE.
![](https://www.zenmoneynews.com/wp-content/uploads/2023/04/newspaper-gdca5e71a2_640-Pixabay.jpeg)